Clinical trial Recruiting at 1 site Observational Ages 50 and up

Observing cognitive impairment in older adults

Official title: Cognitive Impairment in Ageing People: A Longitudinal Observational Prospective Study

Run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT04360200 · Data updated 2026-11-12

This study looks at older adults to see how mild cognitive impairment and dementia develop, hoping to find better ways to prevent and treat these conditions.

Quick facts

Study typeObservational
Ages50 Years and up
SexAll
Enrollment5000 (estimated)
SponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedApril 1, 2020
Main results expectedDecember 2040
Study endsDecember 2040
Registry record updatedSeptember 14, 2020
Trial IDNCT04360200 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals over 50 years old who show signs of mild cognitive impairment but do not meet the full criteria for dementia.

Probably not a fit

Patients with severe mental illness, significant physical disabilities, or those who refuse necessary examinations may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on understanding mild cognitive impairment (MCI) and neurocognitive disorders such as Alzheimer's disease and vascular dementia in elderly populations. It aims to establish a prospective cohort to gather comprehensive epidemiological data and biological samples, which will aid in early prevention, diagnosis, and treatment of cognitive disorders. The study will utilize gene and brain imaging biomarkers to enhance the understanding of dementia pathogenesis and improve targeted interventions. By addressing the rising burden of dementia in China, the study seeks to provide valuable insights into this public health issue.

Why it matters

Potential benefit: If successful, this study could lead to improved early diagnosis and treatment strategies for cognitive impairments in the elderly.

How similar studies have gone: Other studies focusing on cognitive impairment and dementia have shown promise in utilizing biomarkers for diagnosis and intervention, indicating that this approach is supported by previous research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients over 50 years old.
2. Sign informed consent.
3. According to DSM-IV, the diagnostic standard of dementia was not met.
4. The clinical dementia rating (CDR) was 0.5.

Exclusion criteria:

1. Subjects with mental retardation.
2. Refuse to have blood sampling, imaging and other examinations.
3. Uncooperative subjects that have serious organic diseases, or have a history of mental illness, or have physical disability (including severe aphasia).
4. Contraindications of MR scanning.
5. Suffering from serious physical or mental illness.

Where it's running

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.